Two novel junctions in TLN1 mRNA, 18 and 20, were significantly increased in several TCGA cancer patient cohorts compared to healthy control tissue from the Genotype-Tissue Expression (GTEx; Lonsdale et al., 2013) database (Fig. 1 B). This evidence concerns the gene TLN1 and cancer.